최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of liver cancer = 대한간암학회지, v.21 no.1, 2021년, pp.97 - 103
Noh, Minho (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea) , Kim, Beom Kyung (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea) , Kim, Seung Up (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea)
Optimal treatment strategies for patients with advanced hepatocellular carcinoma (HCC) is yet to be determined. Herein, we present a case of advanced HCC with tumor invasion into the right anterior portal vein and right hepatic vein where complete response (CR) was achieved via a multidisciplinary a...
1 Chan SL Chong CCN Chan AWH Poon DMC Chok KS Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016 World J Gastroenterol 2016 22 7289 7300 27621575
2 Díaz-González Á Reig M Bruix J Treatment of hepatocellular carcinoma Dig Dis 2016 34 597 602 27332893
3 Moriguchi M Aramaki T Nishiofuku H Sato R Asakura K Yamaguchi K Sorafenib versus hepatic arterial infusion chemotherapy as initial treatment for hepatocellular carcinoma with advanced portal vein tumor thrombosis Liver Cancer 2017 6 275 286 29234631
4 Yoon SM Ryoo BY Lee SJ Kim JH Shin JH An JH Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial JAMA Oncol 2018 4 661 669 29543938
5 Duffy AG Ulahannan SV Makorova-Rusher O Rahma O Wedemeyer H Pratt D Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma J Hepatol 2017 66 545 551 27816492
6 Colagrande S Inghilesi AL Aburas S Taliani GG Nardi C Marra F Challenges of advanced hepatocellular carcinoma World J Gastroenterol 2016 22 7645 7659 27678348
7 Kim BK Kim DY Byun HK Choi HJ Beom SH Lee HW Efficacy and safety of liver-directed concurrent chemoradiotherapy and sequential sorafenib for advanced hepatocellular carcinoma: a prospective phase 2 trial Int J Radiat Oncol Biol Phys 2020 107 106 115 32084526
8 Han S Lee HW Park JY Kim SU Kim DY Ahn SH Appraisal of long-term outcomes of liver-directed concurrent chemoradiotherapy for hepatocellular carcinoma with major portal vein invasion J Hepatocell Carcinoma 2020 7 403 412 33365287
9 Salem R Gabr A Riaz A Mora R Ali R Abecassis M Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience Hepatology 2018 68 1429 1440 29194711
10 Sangro B Gardini AC Radioembolisation in hepatocellular carcinoma: principles of management Cross T Palmer DH Liver cancers: from mechanisms to management Cham Springer International Publishing 2019 139 152
11 Pawlik TM Poon RT Abdalla EK Zorzi D Ikai I Curley SA Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma Arch Surg 2005 140 450 457 discussion 457–458 15897440
12 Hermanek P Hendson DE Hutter RVP Sobin LH TNM supplement 1993: a commentary on uniform use Heidelberg Springer-Verlag 1993 1 142
13 Edeline J Crouzet L Campillo-Gimenez B Rolland Y Pracht M Guillygomarc’h A Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis Eur J Nucl Med Mol Imaging 2016 43 635 643 26455499
14 Schiro BJ Amour ES Harnain C Gandhi RT Management of high hepatopulmonary shunts in the setting of Y90 radioembolization Tech Vasc Interv Radiol 2019 22 58 62 31079711
15 Theysohn JM Schlaak JF Müller S Ertle J Schlosser TW Bockisch A Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration J Vasc Interv Radiol 2012 23 949 952 22720895
16 Cha H Yoon HI Lee IJ Koom WS Han KH Seong J Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma J Radiat Res 2013 54 1069 1077 23633620
17 Leung TW Lau WY Ho SK Ward SC Chow JH Chan MS Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumors Int J Radiat Oncol Biol Phys 1995 33 919 924 7591903
18 Mokdad AA Singal AG Yopp AC Advances in local and systemic therapies for hepatocellular cancer Curr Oncol Rep 2016 18 9 26769114
19 Hendrickson PG Olson M Luetkens T Weston S Han T Atanackovic D The promise of adoptive cellular immunotherapies in hepatocellular carcinoma Oncoimmunology 2020 9 1673129 32002284
20 Takayama T Sekine T Makuuchi M Yamasaki S Kosuge T Yamamoto J Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial Lancet 2000 356 802 807 11022927
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.